| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 18/06/2024 | 14:05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AMIX | Autonomix Medical Inc |
| 18/06/2024 | 14:00 | GlobeNewswire Inc. | Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial | NASDAQ:AMIX | Autonomix Medical Inc |
| 17/06/2024 | 22:05 | GlobeNewswire Inc. | Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer | NASDAQ:AMIX | Autonomix Medical Inc |
| 10/06/2024 | 14:00 | GlobeNewswire Inc. | Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024 | NASDAQ:AMIX | Autonomix Medical Inc |
| 03/06/2024 | 14:15 | GlobeNewswire Inc. | Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial | NASDAQ:AMIX | Autonomix Medical Inc |
| 31/05/2024 | 23:25 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:AMIX | Autonomix Medical Inc |
| 31/05/2024 | 22:56 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:AMIX | Autonomix Medical Inc |
| 31/05/2024 | 14:05 | GlobeNewswire Inc. | Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update | NASDAQ:AMIX | Autonomix Medical Inc |
| 23/05/2024 | 15:15 | GlobeNewswire Inc. | Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer | NASDAQ:AMIX | Autonomix Medical Inc |
| 14/05/2024 | 22:15 | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series | NASDAQ:AMIX | Autonomix Medical Inc |
| 25/04/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip | NASDAQ:AMIX | Autonomix Medical Inc |
| 24/04/2024 | 15:00 | GlobeNewswire Inc. | Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar | NASDAQ:AMIX | Autonomix Medical Inc |
| 16/04/2024 | 15:00 | GlobeNewswire Inc. | Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain | NASDAQ:AMIX | Autonomix Medical Inc |
| 09/04/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/04/2024 | 14:30 | GlobeNewswire Inc. | Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker | NASDAQ:AMIX | Autonomix Medical Inc |
| 27/03/2024 | 14:00 | GlobeNewswire Inc. | Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference | NASDAQ:AMIX | Autonomix Medical Inc |
| 20/03/2024 | 13:05 | GlobeNewswire Inc. | Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024 | NASDAQ:AMIX | Autonomix Medical Inc |
| 19/03/2024 | 13:45 | GlobeNewswire Inc. | Autonomix Appoints Jennifer Cook as Chief Business Officer | NASDAQ:AMIX | Autonomix Medical Inc |
| 14/03/2024 | 13:15 | GlobeNewswire Inc. | Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market | NASDAQ:AMIX | Autonomix Medical Inc |
| 06/03/2024 | 14:00 | GlobeNewswire Inc. | Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market | NASDAQ:AMIX | Autonomix Medical Inc |
| 29/02/2024 | 14:30 | GlobeNewswire Inc. | Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial | NASDAQ:AMIX | Autonomix Medical Inc |
| 23/02/2024 | 14:50 | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity | NASDAQ:AMIX | Autonomix Medical Inc |
| 22/02/2024 | 14:00 | GlobeNewswire Inc. | Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study | NASDAQ:AMIX | Autonomix Medical Inc |
| 16/02/2024 | 14:00 | GlobeNewswire Inc. | Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market | NASDAQ:AMIX | Autonomix Medical Inc |
| 14/02/2024 | 14:05 | GlobeNewswire Inc. | Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones | NASDAQ:AMIX | Autonomix Medical Inc |
| 06/02/2024 | 14:50 | GlobeNewswire Inc. | Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain | NASDAQ:AMIX | Autonomix Medical Inc |
| 01/02/2024 | 14:35 | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event | NASDAQ:AMIX | Autonomix Medical Inc |
| 31/01/2024 | 14:45 | GlobeNewswire Inc. | Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024 | NASDAQ:AMIX | Autonomix Medical Inc |
| 30/01/2024 | 18:00 | GlobeNewswire Inc. | Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio | NASDAQ:AMIX | Autonomix Medical Inc |
| 30/01/2024 | 15:05 | GlobeNewswire Inc. | Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use | NASDAQ:AMIX | Autonomix Medical Inc |